Propanc Biopharma, Inc. (PPCB): Operating Income
-$18.19M
Year ended 2026-06-30
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2026-06-30 | -$18.19M | n/m | 2026-09-25, From 2025-07-01 |
| 2025-06-30 | -$57.28M | n/m | 2026-09-25, From 2024-07-01 |
| 2024-06-30 | -$1.54M | n/m | 2025-09-29, From 2023-07-01 |
| 2023-06-30 | -$1.78M | n/m | 2024-09-30, From 2022-07-01 |
| 2022-06-30 | -$1.99M | n/m | 2023-09-28, From 2021-07-01 |
| 2021-06-30 | -$1.81M | n/m | 2022-09-28, From 2020-07-01 |
| 2020-06-30 | -$3.49M | n/m | 2021-09-28, From 2019-07-01 |
| 2019-06-30 | -$2.61M | n/m | 2020-10-01, From 2018-07-01 |
| 2018-06-30 | -$3.96M | n/m | 2019-10-15, From 2017-07-01 |
| 2017-06-30 | -$5.74M | n/m | 2018-09-17, From 2016-07-01 |
| 2016-06-30 | -$6.90M | n/m | 2017-09-28, From 2015-07-01 |
| 2015-06-30 | -$1.71M | n/m | 2016-09-28, From 2014-07-01 |
| 2014-06-30 | -$761.2K | n/m | 2015-09-30, From 2013-07-01 |
| 2013-06-30 | -$1.36M | n/m | 2014-10-14, From 2012-07-01 |
| 2012-06-30 | -$11.59M | n/m | 2013-10-15, From 2011-07-01 |
| 2011-06-30 | -$2.24M | n/a | 2012-10-15, From 2010-07-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Propanc Biopharma, Inc. (PPCB) | 2026-06-30 | -$18.19M | n/m |
| Nomad Power Solutions, Inc. (NMAD) | 2025-12-31 | -$5.11M | n/m |
| NRX Pharmaceuticals, Inc. (NRXP) | 2025-12-31 | -$16.22M | n/m |
| Imunon, Inc. (IMNN) | 2025-12-31 | -$14.65M | n/m |
| Turn Therapeutics Inc. (TTRX) | 2025-12-31 | -$5.86M | n/m |
| Anebulo Pharmaceuticals, Inc. (ANEB) | 2025-06-30 | -$9.22M | n/m |
| Edesa Biotech, Inc. (EDSA) | 2025-09-30 | -$7.91M | n/m |
| CalciMedica, Inc. (CALC) | 2025-12-31 | -$23.12M | n/m |
| PRF Technologies Ltd. (PRFX) | 2025-12-31 | -$5.12M | n/m |
Compare PPCB, NMAD, NRXP, IMNN side by side · Screen every company in Pharmaceutical Preparations ↗